Listed

Boyd Group Services Inc.: Form 40-F for the period ended Dec 31, 2025

Filed with the SEC on Mar 18, 2026 and accepted by EDGAR at Mar 18, 2026, 07:23 ET.

Share

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2025-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2025-01-01 to 2025-12-31$3.14bnifrs-full:Revenue
Cost of revenue12 months2025-01-01 to 2025-12-31$1.68bnifrs-full:CostOfSales
Gross profit12 months2025-01-01 to 2025-12-31$1.46bnifrs-full:GrossProfit
Income tax12 months2025-01-01 to 2025-12-31$10.3mifrs-full:IncomeTaxExpenseContinuingOperations
Net income12 months2025-01-01 to 2025-12-31$18.4mifrs-full:ProfitLossAttributableToOwnersOfParent
Diluted EPS12 months2025-01-01 to 2025-12-31$0.82ifrs-full:DilutedEarningsLossPerShare
Basic EPS12 months2025-01-01 to 2025-12-31$0.82ifrs-full:BasicEarningsLossPerShare
Operating cash flow12 months2025-01-01 to 2025-12-31$353.0mifrs-full:CashFlowsFromUsedInOperatingActivities
Capital expenditure12 months2025-01-01 to 2025-12-31$54.3mifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
Cash and equivalentsAt period end2025-12-31$1.23bnifrs-full:CashAndCashEquivalents
Current assetsAt period end2025-12-31$1.50bnifrs-full:CurrentAssets
Total assetsAt period end2025-12-31$3.86bnifrs-full:Assets
Current liabilitiesAt period end2025-12-31$476.7mifrs-full:CurrentLiabilities
Total liabilitiesAt period end2025-12-31$2.14bnifrs-full:Liabilities
Shareholders' equityAt period end2025-12-31$1.72bnifrs-full:Equity
Shares outstandingAt period end2025-12-3127,829,821 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0001193125-26-112466. Last ingested by Listed: Nov 3, 2026, 12:13 ET. Listed shows no prices and gives no investment advice.